Literature DB >> 34313473

Hyperpolarized 129Xe MRI and Spectroscopy of Gas-Exchange Abnormalities in Nonspecific Interstitial Pneumonia.

David G Mummy1, Elianna A Bier1, Ziyi Wang1, Jennifer Korzekwinski1, Lake Morrison1, Christina Barkauskas1, H Page McAdams1, Robert M Tighe1, Bastiaan Driehuys1, Joseph G Mammarappallil1.   

Abstract

Background Recent studies demonstrate that antifibrotic drugs previously reserved for idiopathic pulmonary fibrosis (IPF) may slow progression in other interstitial lung diseases (ILDs), creating an urgent need for tools that can sensitively assess disease activity, progression, and therapy response across ILDs. Hyperpolarized xenon 129 (129Xe) MRI and spectroscopy have provided noninvasive measurements of regional gas-exchange abnormalities in IPF. Purpose To assess gas exchange function using 129Xe MRI in a group of study participants with nonspecific interstitial pneumonia (NSIP) compared with healthy control participants. Materials and Methods In this prospective study, participants with NSIP and healthy control participants were enrolled between November 2017 and February 2020 and underwent 129Xe MRI and spectroscopy. Quantitative imaging provided three-dimensional maps of ventilation, interstitial barrier uptake, and transfer into the red blood cell (RBC) compartment. Spectroscopy provided parameters of the static RBC and barrier uptake compartments, as well as cardiogenic oscillations in RBC signal amplitude and chemical shift. Differences between NSIP and healthy control participants were assessed using the Wilcoxon rank-sum test. Results Thirty-six participants with NSIP (mean age, 57 years ± 11 [standard deviation]; 27 women) and 15 healthy control participants (mean age, 39 years ± 18; two women) were evaluated. Participants with NSIP had no difference in ventilation compared with healthy control participants (median, 4.4% [first quartile, 1.5%; third quartile, 8.7%] vs 6.0% [first quartile, 2.8%; third quartile, 6.9%]; P = .91), but they had a higher barrier uptake (median, 6.2% [first quartile, 1.8%; third quartile, 23.9%] vs 0.53% [first quartile, 0.33%; third quartile, 2.9%]; P = .003) and an increased RBC transfer defect (median, 20.6% [first quartile, 11.6%; third quartile, 27.8%] vs 2.8% [first quartile, 2.3%; third quartile, 4.9%]; P < .001). NSIP participants also had a reduced ratio of RBC-to-barrier peaks (median, 0.24 [first quartile, 0.19; third quartile, 0.31] vs 0.57 [first quartile, 0.52; third quartile, 0.67]; P < .001) and a reduced RBC chemical shift (median, 217.5 ppm [first quartile, 217.0 ppm; third quartile, 218.0 ppm] vs 218.2 ppm [first quartile, 217.9 ppm; third quartile, 218.6 ppm]; P = .001). Conclusion Participants with nonspecific interstitial pneumonia had increased barrier uptake and decreased red blood cell (RBC) transfer compared with healthy controls measured using xenon 129 gas-exchange MRI and reduced RBC-to-barrier ratio and RBC chemical shift measured using spectroscopy. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Wild in this issue.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34313473      PMCID: PMC8487218          DOI: 10.1148/radiol.2021204149

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   29.146


  30 in total

1.  Predicting survival across chronic interstitial lung disease: the ILD-GAP model.

Authors:  Christopher J Ryerson; Eric Vittinghoff; Brett Ley; Joyce S Lee; Joshua J Mooney; Kirk D Jones; Brett M Elicker; Paul J Wolters; Laura L Koth; Talmadge E King; Harold R Collard
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

2.  Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.

Authors:  Kevin R Flaherty; Athol U Wells; Vincent Cottin; Anand Devaraj; Simon L F Walsh; Yoshikazu Inoue; Luca Richeldi; Martin Kolb; Kay Tetzlaff; Susanne Stowasser; Carl Coeck; Emmanuelle Clerisme-Beaty; Bernd Rosenstock; Manuel Quaresma; Thomas Haeufel; Rainer-Georg Goeldner; Rozsa Schlenker-Herceg; Kevin K Brown
Journal:  N Engl J Med       Date:  2019-09-29       Impact factor: 91.245

3.  129Xenon Gas Exchange Magnetic Resonance Imaging as a Potential Prognostic Marker for Progression of Idiopathic Pulmonary Fibrosis.

Authors:  Leith J Rankine; Ziyi Wang; Jennifer M Wang; Mu He; H Page McAdams; Joseph Mammarappallil; Craig R Rackley; Bastiaan Driehuys; Robert M Tighe
Journal:  Ann Am Thorac Soc       Date:  2020-01

4.  Enabling hyperpolarized (129) Xe MR spectroscopy and imaging of pulmonary gas transfer to the red blood cells in transgenic mice expressing human hemoglobin.

Authors:  Matthew S Freeman; Zackary I Cleveland; Yi Qi; Bastiaan Driehuys
Journal:  Magn Reson Med       Date:  2013-09-04       Impact factor: 4.668

5.  Nonspecific interstitial pneumonia: survival is influenced by the underlying cause.

Authors:  Hilario Nunes; Kirsten Schubel; Diane Piver; Eline Magois; Séverine Feuillet; Yurdagul Uzunhan; Zohra Carton; Abdellatif Tazi; Pierre Levy; Pierre-Yves Brillet; Andrew G Nicholson; Marianne Kambouchner; Dominique Valeyre
Journal:  Eur Respir J       Date:  2014-12-23       Impact factor: 16.671

6.  Quantitative analysis of hyperpolarized 129 Xe gas transfer MRI.

Authors:  Ziyi Wang; Scott Haile Robertson; Jennifer Wang; Mu He; Rohan S Virgincar; Geoffry M Schrank; Elianna A Bier; Sudarshan Rajagopal; Yuh Chin Huang; Thomas G O'Riordan; Craig R Rackley; H Page McAdams; Bastiaan Driehuys
Journal:  Med Phys       Date:  2017-05-18       Impact factor: 4.071

7.  A protocol for quantifying cardiogenic oscillations in dynamic 129 Xe gas exchange spectroscopy: The effects of idiopathic pulmonary fibrosis.

Authors:  Elianna A Bier; Scott H Robertson; Geoffry M Schrank; Craig Rackley; Joseph G Mammarappallil; Sudarshan Rajagopal; H Page McAdams; Bastiaan Driehuys
Journal:  NMR Biomed       Date:  2018-11-20       Impact factor: 4.044

8.  Pathologically proved nonspecific interstitial pneumonia: CT pattern analysis as compared with usual interstitial pneumonia CT pattern.

Authors:  Hiromitsu Sumikawa; Takeshi Johkoh; Kiminori Fujimoto; Hiroaki Arakawa; Tomas V Colby; Junya Fukuoka; Hiroyuki Taniguchi; Yasuhiro Kondoh; Kensuke Kataoka; Takashi Ogura; Tomohisa Baba; Kazuya Ichikado; Tomoko Gyobu; Masahiro Yanagawa; Osamu Honda; Noriyuki Tomiyama
Journal:  Radiology       Date:  2014-03-22       Impact factor: 11.105

9.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

10.  Meta-analysis of the radiological and clinical features of Usual Interstitial Pneumonia (UIP) and Nonspecific Interstitial Pneumonia (NSIP).

Authors:  Lukas Ebner; Stergios Christodoulidis; Thomai Stathopoulou; Thomas Geiser; Odile Stalder; Andreas Limacher; Johannes T Heverhagen; Stavroula G Mougiakakou; Andreas Christe
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

View more
  2 in total

1.  Noninvasive diagnosis of pulmonary hypertension with hyperpolarised 129Xe magnetic resonance imaging and spectroscopy.

Authors:  Elianna A Bier; Fawaz Alenezi; Junlan Lu; Ziyi Wang; Joseph G Mammarappallil; Bryan O'Sullivan-Murphy; Alaattin Erkanli; Bastiaan Driehuys; Sudarshan Rajagopal
Journal:  ERJ Open Res       Date:  2022-05-16

2.  Three-dimensional ultrashort echo time magnetic resonance imaging in assessment of idiopathic pulmonary fibrosis, in comparison with high-resolution computed tomography.

Authors:  Xiaoyan Yang; Min Liu; Jianghui Duan; Haishuang Sun; Jing An; Thomas Benkert; Huaping Dai; Chen Wang
Journal:  Quant Imaging Med Surg       Date:  2022-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.